321 related articles for article (PubMed ID: 24334214)
1. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.
Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214
[TBL] [Abstract][Full Text] [Related]
2. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis.
Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G
J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568
[TBL] [Abstract][Full Text] [Related]
3. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
Albert U; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
[TBL] [Abstract][Full Text] [Related]
4. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons.
Skarphedinsson G; Hanssen-Bauer K; Kornør H; Heiervang ER; Landrø NI; Axelsdottir B; Biedilæ S; Ivarsson T
Nord J Psychiatry; 2015 Feb; 69(2):81-92. PubMed ID: 25142430
[TBL] [Abstract][Full Text] [Related]
5. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis.
Cervin M; McGuire JF; D'Souza JM; De Nadai AS; Aspvall K; Goodman WK; Andrén P; Schneider SC; Geller DA; Mataix-Cols D; Storch EA
J Child Psychol Psychiatry; 2024 May; 65(5):594-609. PubMed ID: 38171647
[TBL] [Abstract][Full Text] [Related]
7. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis.
Ivarsson T; Skarphedinsson G; Kornør H; Axelsdottir B; Biedilæ S; Heyman I; Asbahr F; Thomsen PH; Fineberg N; March J;
Psychiatry Res; 2015 May; 227(1):93-103. PubMed ID: 25769521
[TBL] [Abstract][Full Text] [Related]
8. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX
J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260
[TBL] [Abstract][Full Text] [Related]
9. A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION.
McGuire JF; Piacentini J; Lewin AB; Brennan EA; Murphy TK; Storch EA
Depress Anxiety; 2015 Aug; 32(8):580-93. PubMed ID: 26130211
[TBL] [Abstract][Full Text] [Related]
10. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
[No Abstract] [Full Text] [Related]
11. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
[TBL] [Abstract][Full Text] [Related]
12. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
[TBL] [Abstract][Full Text] [Related]
13. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
Bloch MH; Storch EA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
[TBL] [Abstract][Full Text] [Related]
15. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS
JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055
[TBL] [Abstract][Full Text] [Related]
16. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
Skarphedinsson G; Weidle B; Thomsen PH; Dahl K; Torp NC; Nissen JB; Melin KH; Hybel K; Valderhaug R; Wentzel-Larsen T; Compton SN; Ivarsson T
Eur Child Adolesc Psychiatry; 2015 May; 24(5):591-602. PubMed ID: 25239489
[TBL] [Abstract][Full Text] [Related]
17. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
19. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
[TBL] [Abstract][Full Text] [Related]
20. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
Vloet TD; Simons M; Herpertz-Dahlmann B
Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
